CMS proposes to Withdraw Trump Era Most Favored Nation (MFN) Drug Pricing Rule
FDA Law Blog
AUGUST 10, 2021
That proposal was withdrawn by the Trump HHS, but the notion of international reference pricing was subsequently incorporated in an October 2018 HHS Advance Notice of Proposed Rulemaking (ANPR) (see our post here ).
Let's personalize your content